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Genetic Effects of Dioxins in the Spot Test
with Mice
by Rudolf Fahrig
Morethananyotherenvironmental chemicals, dioxins have been inthe limelightofpublic interestforabout
10years. In additiontocarcinogenicity, geneticriskisacauseforconcern. Mutagenicitytestsperformedsofar
do notgive aclearpicture. The mutagenic potential ofdioxins has to be considered weakorabsent. Therefore,
it seemed profitable to investigate comutagenicity and co-recombinogenicity ofdioxins more thoroughly. The
only useful method for investigating comutagenicity and co-recombinogenicity ofdioxins in vivo is the spot
test with mice. In this test system, a number ofcocarcinogens and tumor promoters have shown comutagenic
or co-recombinogenic effects. In the present study, tetrachlorodibenzo-p-dioxin (TCDD) and two environmen-
tal dioxin mixtures [pentachlorodibenzodioxin (PCDD) 1 and 2] were tested for genetic activity. Given alone,
no mutagenic or recombinogenic effects could be observed. In combination with the carcinogenic mutagen
ethyl nitrosourea (ENU) at concentrations of 128 pg/kg for PCCD 2, 314 ,ug/kg for PCDD 1, and 3 fig/kg for
TCDD,adoublingofthe genetic effectiveness ofENUwas observed. The genetic riskcanroughlybeconsidered
as1:0.02forTCDD:PCDD2and1:0.01forTCDD:PCDD1.WhilePCDD land2 seemtoenhancethemutagenicas
well as the recombinogenic potential of ENU, TCDD showed mainly co-recombinogenic and antimutagenic
activity. This characteristic indicates that TCDD is mainly a tumor promoter.
Introduction
The aim ofthis study was to estimate the genetic risk of
two environmental dioxin mixtures in comparison to
2,3,7,8-tetradichlorodibenzo-p-dioxin (TCDD). Itisknown
thatTCDD is carcinogenic (1-5), butitis nearlyineffective
in genotoxicity tests (6-12). Therefore, it did not seem
useful toperformanothertestformutagenicity. Instead, I
examinedcomutagenic andco-recombinogenic effects.The
reason for doing this was a) TCDD has shown cocar-
cinogenic and tumor-promoting activities (13-15) and b) in
yeast and mice, cocarcinogens have shown comutagenic
effects and tumor promoters have shown co-recombino-
genic effects (16-18). The only useful method for the
present study seemed to be the spot test with mice (19)
because inthis test system anumberofcocarcinogens and
tumor promoters have shown comutagenic or co-
recombinogenic effects (16,17). The effect of tumor pro-
moters of the phorbol ester type could be measured at
concentrations as low as 30 pLg/kg. Therefore, the sen-
sitivity of the method includes toxicologically relevant
doses of dioxins.
The spot test was introduced in 1975 for studies of
genotoxicity (19).Theexceptional feature ofthe spottestis
that it allows one to distinguish between induced gene
mutations and induced reciprocal recombinations (16).
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Table l.a
PCDD mixture 1, PCDD mixture 2,
Congeners mg mg
Tox-equivalency (BGA) 2.84 6.29
sum TCDD 4.64 24.03
sum PeCDD 26.48 76.42
sum HxCDD 52.54 136.63
sum HpCDD 114.23 151.74
sum OCDD 239.39 57.53
sum PCDDs 437.29 446.35
TCDD/PCDD (%) 1.06 5.38
PeCDD/PCDD, % 6.05 17.12
HxCDD/PCDD, % 12.02 30.61
HpCDD/PCDD, % 26.12 34.00
OCDD/PCDD, % 54.75 12.89
Abbreviation: BGA, Bundesgesundheitsamt (Federal Health Office).
aProducer: mixture I + II: Institut fur Organische Chemie, Univer-
sitiat Thbingen.
Material and Methods
TCDD of > 98% purity was obtained from Radian
Corporation (Woburn, MA). Ethylnitrosourea (ENU) was
obtained from Ferak (Berlin, Germany). The dioxin mix-
tures used are shown in Table 1.
Spot Test
According to the spot test, mouse embryos, which are
heterozygous for different recessive coat color genes, are
treated in utero between 9 and 11 days afterconceptionby
injection of a mutagen into the peritoneal cavity of theR. FAHRIG
Table 2. Theoretical expectations.
Original state
b/B p/P d/D cch/C p cch/p C
Color spots induced by
Mutation (a) blba p/pa d/da cch/Ca - - -
Deletion (A) b/A p/A d/A ceh/A (p c,h/A) - (P C/A)
Monosomy (o) b/o - d/o - (p ch'/o) _ (P C/o)
Reciprocal recombination b/b p/p dld - p cch/p cch TWin spot P C/P C
Nonreciprocal recombination (*) b/b* p/p* d/d*
Color of spot Brown Light gray Gray Light brown Near-white Maternal black
mother animal or by other appropriate routes of admin-
istration. Ifthis treatment leads to an alteration or loss of
a specific wild-type allele in a pigment precursor cell, a
color spot in the coat ofthe adult animal may appear.
With regard to the mechanism (Table 2) by which the
heterozygous recessivecoat-coloralleles canbeexpressed,
this is either a gene mutation, theoretically also loss ofthe
wild-type allele through deletion or monosomy, arecombina-
tional process such as mitotic crossing-over (reciprocal
recombination), or mitotic gene conversion (nonreciprocal
recombination). Of the numerical and structural chromo-
some aberrations that can lead to loss of the wild-type
allele, onlythose that survive several mitoses would cause
a spot with expression of the recessive allele. In the
routinely performed spot test, three types of spots are
distinguished: a) white midventral spots (which have no
pigment at all). These are regarded as resulting from
pigment cell killing; b) spots with hairs similar to the
yellow hairs which normally surround ears, genital
papillae, and mammae. These are classified as mis-
differentiation spots and appear as yellow fluorescent
hairs with agouti genotype; c) spots of genetic relevance
(SGR) resulting from genetic alterations at the different
gene loci and expressing the recessive mutant or their
wild-type alleles.
Without routinely performed microscopical analysis, it
is notpossible to distinguishbetween the differentmecha-
nisms leading to expression of a recessive mutation. The
only possibility to distinguish between induced mutations
and induced reciprocal recombinations is to use specific
mouse strains and to identify the gene loci involved in
appearance of a color spot by microscopical pigment anal-
ysis (16,20).
The embryos treated were the F1 from the cross C57BI
x T, being homozygous for nonagouti (a/a), and hetero-
zygous for brown (b/B), pink-eyed dilution and chinchilla
(p cch/P C), dilute and short ear (d selD SE), and piebald
spotting (s/S). Mutations of piebald spotting or short ear
cannot be detected using the spot test. Heterozygosity of
the recessive mutant alleles leads to dark gray coat in the
F1. In contrast, the mother animal homozygous for the
wild-type alleles has a black coat.
Gene mutations can now be detected as genetic altera-
tions at the c locus; cch/cch in combination with a/a results
in a dull black or sepia color spot, neither of which con-
trasts clearly from the coat. However, the genetic altera-
tion that can be detected is a mutation ofc or a lethal allele
of c, both of which combined with c h give rise to a light
brown c/cch phenotype. Therefore, light brown spots are
caused onlybygenemutation orsmalldeletions, but notby
recombinations.
It is possible to detect reciprocal recombinations
between thep and clocibecause the loci arelocated on the
same chromosome (14 units apart). A genetic alteration
leadingtop cch/p cch orp cch/A (A = deletion) gives rise to
near-white color spots, the characteristic reduction in
pigmentation being clearly identifiable by microscopical
analysis. Near-white spots are unlikely to be due to gene
mutations because simultaneous mutations at the linked
loci p and c are extremely rare and have never been
observed in specific-locus experiments. It is also highly
unlikelythatlarge deletions involvingboth the c andp loci
are sufficiently viable in the heterozygous form or in the
case of monosomy. The most likely genetic alteration
leading to viable cells of the genotype p cch/p cch is
reciprocal recombination due tomitotic crossing-over. The
corresponding reciprocal product ofmitotic crossing-over
iscellsofthegenotype PC/PC.Thedetection ofPC/PCis
possible because the recessive genes, even in the hetero-
zygous state, have an influence on the level of pigmenta-
tion. In contrast to the homozygous nonagouti black
mother animals, F1 animals are dark gray to black on the
back, and medium gray on the ventral side. Therefore,
pigment cells of the genotype P C/P C show up as black
spots. Color pictures ofspots and hair pigment have been
published recently (20).
Afeature ofmitotic crossing-over is the potentiality for
forming twin spots. A twin spot, homozygous for the
recessivemarkers andtheirwild-type alleles, respectively,
arebothdistinguishable fromtheheterozygousremainder
ofthe body. It is not necessary that both spots should be
visible; thedescendants ofeitherofthedaughtercellsmay
not occupy a position on the surface, orwhere the marker
gene can express itself. Therefore, the appearance oftwin
spots is a rare event.
Results
The results summarized in Table 3 and Figure 1 clearly
show that the dioxin mixtures as well as TCDD enhance
the genotoxicity ofENU. A doubling ofthe effect ofENU
can be observed at different concentrations: 314 pwg/kg
PCDD2, 128 hg/kg PCDD1, and 3 pLg/kg TCDD. Given
alone, 128 pLg/kgPCDD2was ineffective ininducingmuta-
tions or recombinations.
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Table 3. Effect ofdioxins in the spot test.
Fl-animals
with color
Femaleswithvaginal plug Fl-animals spots of
Dose, Day after No. with Fl-animals midventral genetic
Substance ,ug/kg conception No. treated litter 4 weeks old white relevance
PCDD II + ENU 1021 9 79 16 10 2 2
ENU 30,000 9 35 13 57 1 3a
PCDD II + ENU 128 9 109 34 151 13 28b
ENU 30,000 9 61 25 107 8 12
PCDDI+ENU 314 9 84 28 141 25 27
ENU 30,000 9 39 17 98 5 11
PCDDII 128 9 120 38 168 0 1
DMSO 9 120 43 208 1 3
TCDD + ENU 3 9 100 49 178 32 37c
ENU 30,000 9 100 41 223 11 19d
TCDD + ENU 3 9 100 44 198 30 39
ENU 30,000 9 100 42 216 19 27
aOne animal with two spots ofdifferent colors.
bThree animals with two spots ofdifferent colors.
cFour animals with two spots ofdifferent colors.
dTrwo animals with two spots ofdifferent colors.
ENU alone
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ENU PCDD2 alone
s.p.o o n ..rl..e.v.a
spots of genetic relevance
1a0
.2
.
PCDD2 alone
128 ug/kg
PCDD2 + ENU
1021 ug/kg
TCDD + ENU
3 ug/kg
FIGURE 1. Enhancement ofthe genetic effects ofethylnitrosourea by treatment with dioxins.
The results summarized in Table 4 and Figures 2 and 3
allow detection of comutagenic or co-recombinogenic
effects. Considering spots that could havebeeninducedby
both, recombinations and mutations, no influence of
dioxins can be observed. The two dioxin mixtures do not
seem to be able to enhance specifically either the muta-
genic orrecombinogenic effectofENU. Incontrasttothis,
TCDD shows a clear co-recombinogenic and anti-
mutagenic effectiveness. As can be seen in Table 3 and
Figure3,thefrequencyoftwin spotsinducedbyENUand
TCDD is 3.7%. With ENU alone, only2 (0.2%) of858 color
spots were twin spots (21). Within the present positive
controls, with ENU alone no twin spot could be induced. A
clear antimutagenic effect of TCDD is apparent when
comparingthefrequencyoflightbrown spots (Table3 and
Figures 2 and 3). Summarizing, it can be said that the
DMSO control
K. '-.'.....
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Table 4. Distribution ofcolor spots among four gene loci in the mammalian spot test.
Original state
cch/C pCchPC
b/B, p/P, dID, Light Near- Maternal
brown light gray gray brown white TWin spot black
2 spots induced with 1021 jig/kg
PCDD II + ENU were: - 1 1
4 spots induced with ENU alone were: - 2 2 - -
31 spots induced with 128 jig/kg
PCDD II + ENUwere: 7 10 10 3 1
12 spots induced with ENU alone were: 3 7 1 - 1
27 spots induced with 314 p.g/kg
PCDD I + ENUwere: 2 9 10 3 2 - 1
11 spots induced with ENU alone were: 1 6 2 1 1
1 spot after treatment with 128 p.g/kg
PCDD II was: - - 1 - -
3 spots after treatment with 0.01 mL/10 g
DMSO were: 2 - 1 - -
3 kg/kg TCDD + 30 mg/kg ENU
Experiment 1 (41 color spots)a 4 16 14 1 5 - 1
Experiment 2 (41 color spots)a 4 8 19 3 4 3
30 mg/kg ENU
Experiment 1 (20 color spots)a 1 7 8 3 - - 1
Experiment 2 (27 color spots)a 6 6 8 4 3
aTreatment of100 mother animals.
mutation gene reciprocal
or recomb. mutation recombination
ENl
ENL
0 20 40 60 80 100%
FIGURE 2. Percentage ofcolor spots induced either by gene mutation or
by recombination.
dioxin mixtures enhance the genetic effectiveness ofENU
in an unspecific way, whereas TCDD shows clear co-re-
combinogenic and antimutagenic effects.
Discussion
The aim ofthe study was to compare the genetic risk of
two environmental dioxinmixtureswithTCDD. In toxicol-
ogy this is done by introducing equivalency factors using
TCDD = 1 as a reference quantity. Normally, the criteria
for estimation of equivalency factors have nothing to do
with toxicology. Instead, binding affinity and induction of
enzymes are used. The results of such calculations are
insufficient for anyform ofrisk estimation, and especially
for estimation of genetic risks. The present work may be
more useful in this respect. As 3 kg/kg TCDD are as
effective as 128 rLg/kg PCDD2 mixture or 314 pLg/kg
PCDD1 mixture, the genetic risk of TCDD:PCDD2 is
about 1:0.02, and that ofTCDD:PCDD1 about 1:0.01.
In contrastto the two dioxinmixtures, TCDD showed a
specific co-recombinogenic and antimutagenic effect. Such
specific effects have been observed before for several
tumor promoters (16-18).
The relationships between the effects of substances in
carcinogenicity tests and in genetic experiments do not
prove that there is a causal connection between the two
processes, buttheyoffer atleastplausible explanations for
hitherto conflicting results in carcinogenicity experi-
ments. Asimple desmutagenic effect in the genetic experi-
ments can be excluded because of the parallel enhance-
mentofrecombinations. Thus, thegeneticeffects observed
may be relevant to the carcinogenic process.
Ifinitiation is based on mutation, it seemsplausible that
cocarcinogens may act as comutagens. But the question
arises of why tumor promoters promote induction of
recombinations ratherthanmutations. Apossibleexplana-
tion comes from experiments using yeast, in which the
probability that a heterozygous recessive gene becomes
homozygous is two orders of magnitude higher for non-
reciprocal recombination than for gene mutation (22,23).
Also, observations in cultured mouse cells showedthatthe
frequency of nonreciprocal recombination (gene conver-
sion) between repetitive genes is several orders ofmagni-
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FIGUIRE 3. Color spots induced with 3 p.g/kg TCDD plus 30 mg/kg
ethylnitrosourea distributed to different gene loci.
tudehigherthanthefrequencyofgenemutation (24).With
reciprocal recombination, a single event is sufficient to
result in the expression of all recessive mutations of a
chromosomal segment, whereas with gene mutations sev-
eral single events would be needed to achieve a similar
effect. Thus, if a tumor promoter would channel the spon-
taneously occurring genetic alterations into the pathway
of recombination rather than mutation, the chance of
recessive tumor genes (induced by an initiator) being
expressed would be increased. In any case, the co-
recombinogenic effects observed are useful for estimation
of the genetic risk. It is possible to distinguish between
TCDD and other dioxins in respect to the nature oftheir
genetic effectiveness and the strength ofthis effect.
I am grateful for the expert technical assistance of S. Irmer and K.
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